Glutamine synthetase, encoded by the gene GLUL, is an enzyme that converts glutamate and ammonia to glutamine. It is expressed by endothelial cells, but surprisingly shows negligible glutamine-synthesizing activity in these cells at physiological glutamine levels. Here we show in mice that genetic deletion of Glul in endothelial cells impairs vessel sprouting during vascular development, whereas pharmacological blockade of glutamine synthetase suppresses angiogenesis in ocular and inflammatory skin disease while only minimally affecting healthy adult quiescent endothelial cells. This relies on the inhibition of endothelial cell migration but not proliferation. Mechanistically we show that in human umbilical vein endothelial cells GLUL knockdown reduces membrane localization and activation of the GTPase RHOJ while activating other Rho GTPases and Rho kinase, thereby inducing actin stress fibres and impeding endothelial cell motility. Inhibition of Rho kinase rescues the defect in endothelial cell migration that is induced by GLUL knockdown. Notably, glutamine synthetase palmitoylates itself and interacts with RHOJ to sustain RHOJ palmitoylation, membrane localization and activation. These findings reveal that, in addition to the known formation of glutamine, the enzyme glutamine synthetase shows unknown activity in endothelial cell migration during pathological angiogenesis through RHOJ palmitoylation.
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Endothelial cells (ECs) line the lumen of blood vessels. Emerging evidence reveals that EC metabolism controls vessel sprouting (angiogenesis) [1] [2] [3] . Although glutamine catabolism in ECs has been recently characterized 4 , it is not known whether glutamine anabolism controls angiogenesis in vivo. Glutamine is a carbon and nitrogen donor for the production of biomolecules and is involved in redox homeostasis. Most cells take up glutamine, and therefore do not need to synthesize it. However, certain cell types express GLUL (glutamate-ammonia ligase), the gene that encodes the enzyme glutamine synthetase (GS), which is capable of de novo glutamine production from glutamate and ammonia in a reaction that requires ATP and Mg 2+ or Mn
2+
. GS also serves another biochemical function-the clearance of ammoniabut this is best described for hepatocytes, astrocytes and muscle. ECs also express GS 5 , although its role and importance in angiogenesis is unclear given that ECs are exposed to high plasma glutamine levels. Global deficiency of GS causes embryonic lethality, presumably owing to the inability to detoxify ammonia 6 . GS deficiency in humans is extremely rare and leads to multi-organ failure and infant death 7 . Whether and how GS affects angiogenesis has, to our knowledge, not yet been analysed. Here we characterized the role and importance of GS in vessel sprouting.
Vessel sprouting requires endothelial GS
We checked the expression of GS in endothelial cells of the retinal microvasculature with a genetic Glul reporter mouse (Glul +/GFP mice with a nucleus-targeted GFP-lamin A fusion reporter transgene in the Glul open reading frame of one allele 6 ). GFP tracing in the post-natal day (P)5 retinal plexus, co-stained with the endothelial cell marker isolectin B4 (IB4; red), revealed endothelial expression of GFP (and therefore expression of GS) in the microvasculature (Fig. 1a) .
Human umbilical vein ECs (HUVECs) expressed GLUL at similar levels to human colon ECs, liver ECs, human umbilical artery ECs and blood outgrowth ECs, but at a lower level than lung ECs (Extended Data Fig. 1a) . However, the expression of GS in ECs or isolated mouse liver ECs was lower than in HEPG2 hepatocellular carcinoma cells or astrocytes (Extended Data Fig. 1a-c) , which are known to highly express GS. Glutamine withdrawal (below the physiological concentration of 0.6 mM) increased GS protein levels in ECs Article reSeArcH (Fig. 1b, Extended Data Fig. 1b) , as has been previously documented for other cell types 8 . We intercrossed Glul lox/lox mice with two different EC-specific tamoxifen-inducible Cre driver lines-VE-cadherin(PAC)-cre
ERT2
and Pdgfb-cre ERT2 mice-to obtain Glul vECKO and Glul pECKO mice, respectively (in which ECKO indicates endothelial cell knockout; VE-cadherin is also known as Cdh5). Correct recombination of the excised Glul allele was confirmed (Extended Data Fig. 1d , e) and caused an average reduction of 84% in Glul mRNA levels in mouse liver ECs isolated from Glul vECKO mice (Fig. 1c) . In the neonatal retina, vascular plexuses in P5 Glul vECKO mice showed hypobranching and reduced radial expansion, whereas vessel coverage by NG2
+ pericytes (NG2, chondroitin sulfate proteoglycan 4) and vessel regression (number of empty collagen IV + sleeves) were unaffected ( Fig. 1d -h, Extended Data Fig. 1f, g ). However, the numbers of filopodia at the vascular front and of distal sprouts with filopodia, both parameters of EC migration, were lower in Glul vECKO mice (Fig. 1i, j) . Furthermore, the complexity of the vasculature at the utmost leading front of the plexus was decreased, as determined by counting the number of branches in distal sprouts (Extended Data Fig. 1h ). By contrast, quantification of IB4
+

EdU
+ cells (EdU, 5-ethynyl-2′-deoxyuridine) revealed no difference in the number of proliferating ECs (Fig. 1k-m, Extended Data Fig. 1i ). Hypobranching was also observed in the dorsal dermal blood vasculature in embryonic day (E)16.5 Glul vECKO embryos (Fig. 1n-r) . A similar retinal phenotype was observed in Glul pECKO mice (Extended Data Fig. 1j-m) . Therefore, loss of endothelial GS causes vascular defects by impairing EC migration but not proliferation.
The retinal vascular defect was restored over time (Extended Data Fig. 1n-u) , and at six weeks, Glul vECKO mice (with Glul deleted in ECs at P1-P3) did not show overt vascular defects (Extended Data Fig. 1v-ag) . Glul vECKO mice gained normal body weight, and blood biochemistry and haematological profiles were normal at six weeks (Extended Data Table 1 ). Vascular restoration may relate to the possibility that homozygous mutant ECs were outcompeted over time by residual wild-type ECs, in which recombination did not occur (as documented in mice with endothelial knockout of other key metabolic genes 9 ) or because of other compensatory adaptations. Alternatively, the results raise the question of whether the effect of endothelial GS loss may be larger in growing (motile) ECs during vascular development than in quiescent (non-motile) ECs during adulthood in healthy conditions.
We then explored whether pharmacological blockade of GS with methionine sulfoximine (MSO), which irreversibly blocks the catalytic activity of GS, reduced pathological angiogenesis. First, in the oxygen-induced model of retinopathy of prematurity (ROP) 2, 3 , the treatment of pups with MSO reduced the formation of pathological vascular tufts (Fig. 2a-c) , while modestly increasing the vaso-obliterated area (Fig. 2d, Extended Data Fig. 1ah, ai) . Second, we used the corneal micro-pocket assay, with slow-release pellets containing basic Article reSeArcH fibroblast growth factor (bFGF) as a mouse model of corneal neovascularization. Inclusion of MSO in the pellet reduced the formation of new CD31
+ blood vessels in the otherwise avascular cornea (Fig. 2e-g ). Finally, we used an imiquimod (IMQ)-based mouse model of inflammation-driven skin psoriasis, and found a marked dose-dependent reduction of the CD105 + EC area upon topical treatment of the affected skin with MSO ( Fig. 2h-l) . Therefore, pharmacological GS blockade inhibits pathological angiogenesis in the inflamed skin and in several eye disorders.
Silencing GLUL reduces EC migration
We then used GLUL knockdown (GLUL KD ) HUVECs (mediated by short hairpin RNA (shRNA); >80% silencing; Extended Data Fig. 2a ) in in vitro spheroid-sprouting assays to assess vessel sprouting. GLUL KD ECs showed a reduced number of sprouts per spheroid and a reduction in the total sprout length (Fig. 3a, b , e, f). Re-introduction of a shRNA-resistant GLUL (rGLUL OE ; in which r indicates shRNA-resistance and OE indicates overexpression) rescued the sprouting defect (Extended Data Fig. 2b, c) . The sprouting defect in GLUL KD spheroids was maintained upon mitotic inactivation of ECs with mitomycin C (Fig. 3c-f) , which further suggests a defect in EC motility. In agreement with this, at physiological glutamine levels GLUL knockdown did not affect EC proliferation (Fig. 3g) . The sprouting defect was also not due to reduced EC viability or increased oxidative stress, or to changes in energy charge, glutathione or NADPH levels, glycolysis, glucose or glutamine oxidation, or oxygen consumption (Extended Data Fig. 2d-m) .
GLUL KD ECs showed impaired migration in scratch-wound and Boyden chamber assays, even upon treatment with mitomycin C, an effect that was rescued by re-introducing the shRNA-resistant GLUL (rGLUL OE ) (Fig. 3h, i) . Furthermore, sparsely seeded GLUL KD ECs had a reduced velocity of random movement (Fig. 3j , Supplementary Videos 1, 2) and a decreased lamellipodial area (Fig. 3k-m) . Comparable results were obtained with a second non-overlapping shRNA and a GLUL-specific small interfering RNA (siRNA) (Extended Data Figs. 2a, 3a-e) .
The migration defects suggested that the remodelling of the actin cytoskeleton, which is necessary for cellular motility, was perturbed in GLUL KD ECs. Notably, we detected an increase in F-actin levels in GLUL KD ECs (Fig. 3n) . A role for GS in cytoskeletal remodelling was further suggested by analysing the repolymerization of the actin cytoskeleton upon disruption with the F-actin polymerization inhibitor latrunculin B and subsequent wash-out. Latrunculin B perturbed the normal morphology of control and GLUL KD ECs (Fig. 3o-r) . After wash-out, when control cells had rebuilt a normal actin cytoskeleton, GLUL KD ECs still had higher F-actin levels, which mainly originated from increased numbers of stress-fibre bundles (Fig. 3s-u) . GLUL KD ECs did not display altered α-tubulin levels (Fig. 3v , Extended Data Fig. 4a-h ).
The increase in F-actin levels was also present in ECs that were freshly isolated from MSO-treated mice (Extended Data Fig. 4i-k) , and in confluent GLUL KD ECs aligning a scratch wound in vitro (Extended Data Fig. 4l-n) . Confluent monolayer GLUL KD ECs displayed compromised junctional integrity (Extended Data Fig. 4o-v) . Functionally, this corresponded to a decrease in the transendothelial electrical resistance of GLUL KD ECs in vitro (Extended Data Fig. 4w ) and increased leakiness of inflamed (but not healthy) vessels in vivo (Extended Data Fig. 4x-z) .
Glutamine production by endothelial GS
To explore whether the migration defect was attributable to reduced de novo glutamine synthesis, we measured the glutamine-synthesizing activity of GS by supplementing ECs with 15 NH 4 Cl (Extended Data Fig. 5a ). At a physiological concentration of 0.6 mM glutamine or higher, the glutamine-producing activity of GS was negligible, at approximately the level observed in ECs treated with MSO. It slightly increased only upon glutamine withdrawal, presumably to compensate for the lack of available glutamine (Fig. 4a) . Similar results were obtained in a medium containing dialysed serum (Extended Data  Fig. 5b ). For further details see Supplementary Discussion 1 and Extended Data Fig. 5c -n.
To determine whether the phenotype of GLUL KD ECs relied on the catalytic site of GS, we used MSO-which is an irreversible inhibitor of GS by competing with glutamate for binding at the catalytic site-at previously reported concentrations 10 . MSO reduced EC spheroid sprouting, impaired EC migration in scratch-wound assays under treatment with mitomycin C, and decreased lamellipodial area, while increasing F-actin levels after latrunculin B wash-out but not affecting EC proliferation (Extended Data Fig. 5o-t) . Even though other (off-target) effects of pharmacological GS inhibition cannot be MSO (b). Quantification of vascular tuft (c) and vaso-obliterated area (d) in control and MSO-treated ROP mice. e-g, Quantification (e) of CD31 + (green) neo-vessels in corneal flat-mounts from mice in corneal pocket assays with bFGF pellets (demarcated by a dotted white line) with vehicle (f) or MSO (g). h-l, CD105 staining of untreated skin (h), IMQtreated skin (i), IMQ + low-dose MSO-treated skin (j), IMQ + high-dose MSO-treated skin (k) and quantification of CD105 + area (l). All data are mean ± s.e.m., with individual data points shown for c, d, e and l; values of n (individual mice) for control and MSO-treated are: 7 and 6 (c, d), 10 and 11 (e) from 3 litters (c, d) and 2 experiments (e). In l, n = 15 mice for control, n = 22 for IMQ, n = 18 for IMQ + MSO low-dose (indicated by +), and n = 6 for IMQ + MSO high-dose (indicated by ++) from 3 experiments. NS, P > 0.05, *P < 0.05 according to Student's t-test (c, d, e) or one-way analysis of variance (ANOVA) with Dunnett's multiple comparisons versus IMQ (l). Exact P values are as follows: 0.0459 (c); 0.0145 (d); <0.0001 (e); control versus IMQ: 0.0278; MSO low versus IMQ: 0.7283; MSO high versus IMQ: 0.0451 (l). Scale bars: 100 µm (a, b),
Article reSeArcH formally excluded, MSO phenocopied the GLUL knockdown, which suggests that the catalytic site of GS is indispensable in the control of EC cytoskeletal homeostasis.
GS inhibition affects RHOJ activity
Because small GTPases and their effectors control F-actin levels and motility 11 , we explored whether Rho GTPases were downstream targets of GS. We focused on RHOJ, because it is mainly expressed in ECs 12 and because the blocking of endothelial RHOJ has been proposed as a novel anti-angiogenesis approach 13 . It is noteworthy that RHOJ KD ECs fully phenocopied GLUL KD ECs in terms of decreased mobility and barrier function (data not shown).
Because RHOJ localizes to plasma and organelle membranes to become activated 14 , and is almost exclusively detected in the membrane fraction 15 , we investigated whether its membrane localization and activity were regulated by GS levels. Immunoblotting revealed that RHOJ was detectable only in the membrane fraction of ECs (consistent with previous findings 15 ) , and that GLUL KD ECs had decreased amounts of RHOJ in the membrane fraction (without concomitant increase in the cytosolic fraction, possibly because of proteasomal degradation 16 ) as well as decreased levels of active RHOJ (Fig. 4b, c) . GLUL knockdown did not clearly affect RHOJ transcript levels (relative mRNA levels: 0.99 ± 0.03 in control compared with 0.85 ± 0.05 in GLUL KD ; n = 3, P = 0.0282). We also explored whether GLUL knockdown affected other Rho GTPases in ECs. We focused on the RHOA/B/C-Rho kinase (ROCK)-myosin light chain (MLC) axis, because silencing of endothelial RHOJ increases signalling of this pathway and induces aberrant F-actin stress-fibre formation through an as-yet-undefined mechanism 13, 17 ( Fig. 4d) . Standard glutathione S-transferase-Rhotekin pull-down assays showed that GLUL knockdown increased the activity of RHOA and RHOC, but not of RHOB ( Fig. 4e-g ). Of note, GLUL knockdown, much like other stimuli, increased total RHOB levels. We confirmed the increase in RHOA activity at the individual-cell level with a DORA-RHOA-FRET (DORA, dimerization optimized reporter for activation; FRET, fluorescence resonance energy transfer) biosensor (Fig. 4h, Extended Data Fig. 6a ). We observed that the abnormally elevated RHOA activity in retracting lamellipodia in GLUL KD ECs evoked more numerous, but smaller and more short-lived, lamellipodia (Fig. 4i) , which could contribute to the motility impairment. As previously suggested 18 , increased RHOA activity in lamellipodia leads to local actomyosin contraction through ROCK and phosphorylated MLC (pMLC), thereby prematurely retracting the lamellipodium. Combining both GLUL and RHOJ knockdown did not further increase RHOA activity (data not shown); this confirms that RHOJ silencing by itself increased RHOA activity, and suggests that GS primarily acts via RHOJ to control RHOA signalling.
Downstream of Rho GTPases, GLUL KD and MSO-treated ECs had increased ROCK1 and ROCK2 protein levels ( Fig. 4j) and enhanced ROCK activity, as determined by pMLC protein levels, which were similarly induced in both GLUL KD and RHOJ KD ECs (Fig. 4k , Extended Data Fig. 6b-n) . In agreement with this, ROCK inhibitors (Y27632, fasudil hydrochloride and H1152 dihydrochloride (data not shown)) rescued the phenotype associated with GLUL KD (Fig. 4l -o, Extended Data Fig. 6o-w) , whereas myosin light-chain kinase inhibitors (ML7; peptide 18) did not (Extended Data Fig. 6x-aa) . This suggests that MLC phosphorylation through ROCK rather than through myosin light-chain kinase is more important in mediating the phenotype associated with GLUL KD in ECs. Therefore, GLUL knockdown reduces the membrane localization and activity of RHOJ, while activating RHOA, RHOC and ROCK.
We next explored which of these Rho GTPases interact with GS, assuming that such an interaction might facilitate and/or be necessary for their activation; we remained mindful, however, that RHOJ can negatively regulate the activity of the RHOA-ROCK-MLC axis 13, 17 , and hence the loss of a primary interaction of GS with RHOJ could indirectly explain the increased levels and/or activity of RHOA, ROCK and pMLC upon GLUL knockdown. First, co-immunoprecipitation assays revealed an interaction between endogenous RHOJ and GS (Fig. 5a) ; such an interaction was not observed for RHOA or for RHOC, which is the most abundant Rho GTPase in ECs (Extended Data Fig. 7a) . Second, deletion of the first 20 N-terminal amino acids of RHOJ (ΔN20-RHOJ), which mediate its plasma-membrane localization 19 , reduced the interaction with GS (Extended Data Fig. 7b ). Third, (m) . n-p, F-actin and G-actin levels in phalloidin (F-actin)-DNase I (G-actin) double-stained control and GLUL KD ECs (n), and representative images of phalloidin-stained control (o) and GLUL KD (p) ECs. q-u, Phalloidin staining of latrunculin B-treated control (q, s) and GLUL KD (r, t) ECs at time point 0 (q, r) and at 1 h after latrunculin wash-out (s, t) and quantification of F-actin levels after wash-out (u). v, α-Tubulin levels in GLUL KD and control ECs. All data are mean ± s.e.m., with individual data points shown for e-j, m, n, u and v; values of n (independent experiments) are: 4 (e, f), 9 (g, j), 5 (h), 6 (i, u), 7 (m) and 3 (n, v). NS, P > 0.05, *P < 0.05 according to mixedmodels R statistics (e, f), Student's t-test (g, h, j, m, n, u, v) or one-way ANOVA with Dunnett's multiple comparison versus control (i Article reSeArcH immunoblotting showed that only RHOJ, and not RHOA or RHOC, was predominantly membrane-localized (Extended Data Fig. 7c ). Fourth, we confirmed the GS-RHOJ interaction with a bimolecular fluorescence complementation approach (Extended Data Fig. 7d, e) . On the basis of the above data, we focused on RHOJ as the most likely interaction partner of GS.
To interact with membrane-localized (active) RHOJ, GS should be similarly located; indeed, cell fractionation studies revealed that a fraction of GS was membrane-localized (Fig. 5b) . Further evidence is derived from single-particle tracking data, acquired by photoactivated localization microscopy imaging (SPT-PALM) combined with total internal reflection fluorescence microscopy (TIRF). We traced the movement of single GS proteins that were tagged with the photoswitchable fluorescent protein mEOS (GS-mEOS). Single GS-mEOS particles had a lower diffusion coefficient in the TIRF region (comprising the plasma membrane and the immediately adjacent cytoplasm) than did free mEOS, which is indicative of an association of GS with membrane structures (Fig. 5c, Extended Data Fig. 7f ).
Palmitoylation of GS and RHOJ
Membrane localization often requires post-translational palmitoylation. We therefore proposed that GS could be palmitoylated to enable plasma membrane localization and interaction with RHOJ. We performed click chemistry with biotin azide (Extended Data Fig. 7g ) on lysates from HEK293 cells that overexpressed GS and had been treated with the clickable palmitoylation probes 16C-BYA or 16C-YA. Subsequent streptavidin pull-down showed that both probes labelled GS, which was a clear indication that GS had been palmitoylated. The labelling was reduced by MSO, which is consistent with the presumed dependency of the phenotype on the catalytic site of the enzyme (Fig. 5d) .
The palmitoylation of GS has previously been reported anecdotally, however in-depth molecular and functional characterization was not carried out 20 . To determine whether GS undergoes autopalmitoylation, we incubated purified GS 21 with palmitoyl-alkyne coenzyme A (palmitoylalkyne CoA; a substrate for palmitoylation) in a cell-free system without any other proteins present, to demonstrate a direct effect. Click α-Tub Article reSeArcH chemistry revealed that increasing the dose of palmitoyl-alkyne CoA resulted in increased autopalmitoylation of GS (Fig. 5e) . Importantly, autopalmitoylation of GS was achieved with physiological concentrations of palmitoyl-alkyne CoA (1-10 µM) at neutral pH, which suggests physiologically relevant autopalmitoylation; this was subsequently confirmed with two alternative methods (Supplementary Discussion 2 and Extended Data Fig. 7h-j) .
Palmitoylation of target proteins by palmitoyl-acyl transferases is a two-step reaction, requiring first autopalmitoylation of the palmitoylacyl transferase, followed by transfer of the palmitoyl group to the target protein. We considered that GS could have a similar activity profile (Supplementary Discussion 3) and explored whether it was involved in the palmitoylation of RHOJ. Even though the cysteines at positions 3 (C3) and 11 (C11) of RHOJ were predicted by in silico methods to be high-fidelity palmitoylation sites (screened with SwissPalm 22 , data not shown), the palmitoylation of RHOJ has been poorly documented, with the exception of a few studies 23, 24 . Notably, the membranelocalization and activity of RHOJ were reduced by treatment of ECs with the pan-palmitoylation inhibitor 2-bromopalmitate and by introducing point mutations in C3 and C11 (Fig. 5f , Extended Data Fig. 7k-t) , providing initial evidence that RHOJ can be palmitoylated in ECs. Using the palmitoylation probe 17-ODYA (Fig. 5g) or an acylresin-assisted capture (Extended Data Fig. 7u ), we found a reduction in the levels of palmitoylated RHOJ upon blocking GS, which is consistent with a model whereby GS sustains palmitoylation of RHOJ.
Discussion
We have found that GS is active in the regulation of EC motility. This activity is presumably independent of glutamine synthesis, although we cannot formally exclude a possible contribution of minimal levels of glutamine production by GS to the observed phenotype. GS was found to regulate RHOJ signalling in cell motility, as shown by several forms of evidence. First, a fraction of GS is present in EC membranes, which is where active RHOJ resides. Second, GS interacts with RHOJ in ECs in co-immunoprecipitation experiments, although this interaction could be direct or indirect. Third, GLUL knockdown reduces the palmitoylation of RHOJ, its membrane localization and its activity in ECs. Therefore, because RHOJ promotes EC motility 13, 17 , the impaired migration of GLUL KD ECs could be attributed to a reduction in RHOJ activity. RHOJ probably also indirectly contributes to promoting EC motility by controlling the activity of the RHOA-ROCK-MLC signalling pathway, which is known to regulate EC motility by affecting stress-fibre formation 13, 17 (Extended Data Fig. 7v , Supplementary Discussion 4).
Because purified GS seems to be capable of autopalmitoylationa feature of palmitoyl-acyl transferase enzymes-and because GLUL silencing decreases the palmitoylation of RHOJ, our data support a model whereby GS first palmitoylates itself and then transfers the palmitoyl group to RHOJ, although we cannot formally exclude the possibility that transfer of the palmitoyl group from GS to RHOJ occurs via additional partners or even non-enzymatically. A possible model for GS palmitoylation is described in Supplementary Discussion 5, Extended Data Fig. 8 and Extended Data Table 2 . In addition, whether GS interacts exclusively with RHOJ or whether it can interact with other proteins (for example, other palmitoylated Rho GTPases such as RAC1, CDC42, RHOU or RHOV) to mediate this effect on EC motility is yet to be clarified. In any case, RHOJ seems to be a critical target of GS, given that its silencing completely phenocopies GS inhibition in ECs.
Finally, GS is critical for EC motility and migration, which contributes to the formation of new vessels in development and disease. By contrast, ECs do not migrate when they are quiescent in healthy adults, which explains why GS inhibition has no observable effects on the vasculature in healthy adult mice. This renders GS an attractive disease-restricted target for the therapeutic inhibition of pathological angiogenesis. Furthermore, the pharmacological GS blocker MSO reduced pathological angiogenesis in blinding eye and psoriatic skin disease (Fig. 2) , which warrants further exploration of GS targeting in anti-angiogenesis.
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Article reSeArcH MEthodS
Chemicals and reagents. The GS inhibitor l-methionine sulfoximine (MSO), mitomycin C, latrunculin B, oligomycin, antimycin A, carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), 2-bromohexadecanoic acid (2-bromopalmitic acid, 2BP), tamoxifen, palmitoyl-CoA agarose and α-ketoglutarate dehydrogenase were from Sigma-Aldrich. 17-Octadecynoic acid (17-ODYA) and biotin-azide were purchased from Cayman Chemical. The use and/or synthesis of the other palmitoylation probes 15-hexadecynoic acid (16C-YA; a palmitatebased probe that binds a broader spectrum of proteins than does 16C-BYA (below), including both palmitoyl-acyl transferases and palmitoyl-acyl transferase target proteins) and 2-bromooctadec-15-yonic acid (16C-BYA; a 2-bromopalmitate-based activity-based probe that labels but also inhibits palmitoyl-acyl transferase enzymes) has previously been described 25 . The ROCK kinase inhibitor Y27632 ((R)-(+)-trans-4-(1-aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide) was from BioVision, fasudil hydrochloride and H1152 dihydrochloride were from Tocris. The myosin light-chain kinase inhibitors ML7-hydrochloride and peptide 18 were from Tocris. Collagen type 1 (rat tail) was obtained from Merck Millipore. [5- In brief, blood samples (obtained under protocol S57123 (Commission Medical Ethics of UZ/KU Leuven)) were diluted with PBS before Ficoll PaquePLUS (GE Healthcare) density-gradient centrifugation at 1,000g for 20 min at room temperature. The mononuclear cell layer was collected, washed with PBS and resuspended in EGM2 medium (PromoCell). Cells were plated in collagen-coated flasks and the medium was replaced every 2 days. From day 7 onwards, cells were checked for the formation of colonies, which were allowed to grow to approximately 1 cm 2 . Blood outgrowth EC colonies were then trypsinized and subcultured. HEK293T and HEPG2 cells. Cells (obtained from the ATCC) were grown in DMEM, supplemented with 10% FBS, 100 U ml −1 penicillin and 100 µg ml
streptomycin. When HEPG2 cells were compared directly to ECs in short-term stable isotope tracing experiments, they were incubated in exactly the same medium as the ECs to rule out possible bias arising from the difference in medium formulation. We did not perform authentication of the HEK293T and HEPG2 cells. Mouse liver ECs. Cells were isolated from perfused healthy livers of control or Glul ECKO mice. Before perfusion, the mice were anesthetized with Nembutal (60 mg kg −1 ). Mice were perfused with 5 ml of a water-based perfusion buffer containing 1.7 M NaCl, 84 mM KCl, 120 mM HEPES and 1 mM NaOH followed by 5 ml of a PBS-based digestion buffer containing 0.1% collagenase II (Life Technologies), collagenase I (Life Technologies), 2 mM CaCl 2 , 1% antibioticantimycotic (Life Technologies) and 10% FBS (Biochrom) at a perfusion rate of 1 ml min −1
. Perfusion was considered complete when the liver and mesenteric vessels were blanched and the desired amount of digestion buffer (≥5 ml) had passed through the circulatory system. Livers were dissected, placed into a 50 ml conical tube with 3 ml of digestion buffer and incubated at 37 °C for approximately 30 min, with regular shaking of the tubes every 5 min. After digestion, the tissue was homogeneously dissociated and the reaction was stopped with 10 ml of isolation buffer containing PBS + 0.1% BSA (Sigma-Aldrich). Subsequently, the cell suspension was filtered through a 100-µm cell strainer and cells were washed twice with isolation buffer. Finally, the ECs were isolated by magnetic-bead sorting with Dynabeads (CELLection Biotin Binder Kit, Life Technologies) coated with antimouse CD31 (eBioscience, Anti-Mouse CD31 Clone 390), according to the manufacturer's instructions. In brief, the cell suspension was incubated with the beads at room temperature for 30 min in HulaMixer Sample Mixer (Life Technologies).
Next, CD31
+ ECs were collected by putting the tubes on a DynaMag-50 Magnet (Life Technologies) and removing the supernatant. The procedure was repeated twice to remove cell debris. Finally, cells were resuspended in EGM2 medium (PromoCell) and plated at the desired density on cell-culture plates pre-coated with 0.1% gelatin, and grown to confluency. Mouse astrocytes. The cells were prepared as previously described with minor changes 27 . In brief, spinal cords were dissected from 13-day-old C57BL/6J mouse embryos. Meninges and dorsal root ganglia were removed and a single cell population was obtained by digestion with 0.05% trypsin in combination with gentle trituration. The cell suspension was layered on a 6.2% OptiPrep (Axis-Shield) cushion and centrifuged at 500g for 15 min. The pellet was resuspended and the cells were plated (12,000 cells per cm 2 ) in L15 medium supplemented with glucose (3.6 mg ml ) and FBS (10%). After reaching confluency, cell division was halted by treatment with cytosine arabinoside (10 µM, 3 days). After 4 weeks, more than 95% of cells stained positive for glial fibrillary acidic protein (not shown). We routinely tested primary cells and cell lines for mycoplasma contamination with the MycoAlert mycoplasma detection kit (Lonza, LT07-418). Plasmid constructions and lentiviral particle production. cDNA for human GLUL was obtained from Origene. Silent mutations were introduced to make the GLUL cDNA resistant to the GLUL-specific shRNA (see below, TRCN0000045628). Constructs with point mutations were generated with Stratagene's QuickChange site-directed-mutagenesis kit following the manufacturer's guidelines. The cDNA for RHOJ-eGFP (GFP-TCL) was a gift from C. Der (Addgene plasmid 23231) 23 and was used as a template to generate the N-terminal-truncated ΔN20-RHOJ-eGFP, which lacked the first 20 amino acids, and Flag-tagged RHOJ. Standard cloning techniques were used to fuse GS to the photoswitchable fluorescent protein mEOS (pRSETa-mEos2 was a gift from L. Looger; Addgene plasmid 20341) 28 . The bimolecular fluorescence complementation (BiFC) approach vector enabling simultaneous expression of two separate cDNAs fused to eGFP subfragment 1 (N-terminal; containing amino acids 1 to 158) or subfragment 2 (C-terminal; containing amino acids from 159 onwards), respectively, was a gift from H. Mizuno (KU Leuven). GS was fused to the N-terminal subfragment of eGFP and RHOJ was fused to the C-terminal subfragment of eGFP to generate GS-eGFP in Extended Data Fig. 2a and only used to confirm the migration and lamellipodial defect in Extended Data Fig. 3a, b) and RHOJ-specific (TRCN0000047606) shRNAs were either used in the pLKO.1 vector or subcloned into the pLVX-shRNA2 vector (PT4052-5; Clontech, Westburg BV). Scrambled shRNAs or the empty vectors were used as negative controls (both with the same outcome). All constructs were sequence-verified. Lentiviral particles were produced in HEK293T cells as previously described 2 .
Recombinant protein production. Template vectors pRRLhGS, pRRLhGS
R324C
and pRRLhGS R341C containing the genes encoding wild-type GLUL or GLUL with point mutations were used as templates for PCR-based cloning. Recombinant constructs were expressed in the Escherichia coli strain BL21 codon + pICA2 that was transformed with pLH36-hGS in which expression is induced by isopropyl 29, 30 . The pLH36 plasmid is provided with a His6-tag followed by a murine caspase-3 site. The murine caspase-3 site can be used for the removal of the His6-tag attached at the N terminus of the protein of interest during purification. The transformed bacteria were grown in 200 ml Luria Bertani medium supplemented with ampicillin (100 µg ml ) and 1% glycerol. The initial stirring and airflow was 200 r.p.m. and 1.5 l min −1 , respectively. Further, this was automatically adapted to keep the pO 2 at 30%. The temperature was kept at 28 °C. The cells were grown to an optical density at 600 nm (OD 600 nm ) of 1.0, transferred at 20 °C, and expression was induced by addition of 1 mM isopropyl β-D-1-thiogalactopyranoside overnight. Cells were then collected and frozen at −20 °C. After thawing, the cells were resuspended at 3 ml g −1 in 50 mM HEPES pH 7.5, 500 mM NaCl, 20mM imidazole, 1 mM phenylmethylsulfonyl fluoride, 10% glycerol, 5 mM β-mercaptoethanol, 1 mg per 100 ml DNaseI (Roche) and 1 tablet per 100 ml Complete Protease Inhibitor (Roche). The cytoplasmic fraction was prepared using the Emulsiflex C3 (Avestin) followed by centrifugation. All steps were conducted at 4 °C. The clear supernatant was applied to a 20 ml Ni-Sepharose 6 FF column (GE Healthcare), equilibrated with 50 mM HEPES pH 7.5, 500 mM NaCl, 20 mM imidazole, 10% glycerol, 5 mM β-mercaptoethanol and 1 mM phenylmethylsulfonyl fluoride. The column was eluted with 50 mM HEPES pH 7.5, 500 mM NaCl, 400 mM imidazole, 10% glycerol, 5 mM β-mercaptoethanol and 1 mM phenylmethylsulfonyl fluoride after an intermediate elution step with 50 mM imidazole in the same buffer. Finally, the elution fraction was injected on a HiLoad 26/60 Superdex prep grade column with 20 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol and 0.5 mM tris(2-carboxyethyl)phosphine as running solution. The obtained elution fractions were analysed by SDS-PAGE. Recombinant protein concentration was determined using the Micro-BCA assay (Pierce). In vitro knockdown and overexpression strategies. To minimize off-target effects and other silencing artefacts, key findings were confirmed with at least two independent and validated GLUL-specific shRNAs (see above) and appropriate controls or with a GLUL-specific siRNA duplex (5′-GGAAUAG CAUGUCACUAAAGCAGGC-3′) and scrambled control (TriFECTa, IDT). For lentiviral transduction of shRNAs or overexpressing constructs a multiplicity of infection (MOI) of 10 or 5 was used, respectively. In the case of simultaneous transduction of two different shRNAs, a MOI of 7.5 was used for each individual shRNA. In the case of simultaneous transduction of a shRNA in combination with an overexpression construct, the shRNA was transduced at a MOI of 10 and the overexpression construct at a MOI of 5, except for overexpression constructs for shRNA-resistant GLUL which were transduced at a MOI of 2.5. Transductions were performed on day 0 in the evening, cells were refed with fresh medium on day 1 in the morning and experiments were performed from day 3 or 4 onwards. siRNA transfection mixtures (in a total volume of 500 µl) were prepared in Opti-MEM containing GlutaMAX-I (Invitrogen) with Lipofectamine RNAi Max transfection reagent (Invitrogen) according to the manufacturer's instructions. The mixtures were added to the cells (150,000 cells in a 6-well-format plate) together with 2 ml EBM2 without antibiotics for overnight transfection, after which the medium was changed back to the regular M199 culture medium. siRNA transfection was performed at least 48 h before functional assays. BiFC plasmids were transfected into HEK293T cells with Fugene HD transfection reagent following the manufacturer's guidelines. Knockdown efficiency and overexpression levels were closely monitored for each experiment either on the mRNA (by PCR with reverse transcription; RT-PCR) or the protein level. RNA isolation and gene expression analysis. Total RNA was extracted with PureLink RNA mini kit (Invitrogen) according to the manufacturer's instructions; quality and quantity were measured on a Nanodrop (Thermo Scientific). cDNA synthesis was performed with the iScript cDNA synthesis kit (BioRad). qPCR analyses were performed as previously described 1 on an Applied Biosystems 7500 Fast device with in-house-designed primers and probes or premade primer sets (Applied Biosystems or Integrated DNA Technologies) for which sequences and/or primer set ID numbers are available upon request. ENOX2 or HPRT1 were used as housekeeping genes. Western blotting and (co-)immunoprecipitation. Proteins were extracted in Laemmli buffer (125 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol) or in RIPA buffer (25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) containing protease and phosphatase inhibitor mixes (Roche Applied Science). After shearing of genomic DNA, proteins in the lysates were separated by SDS-PAGE, transferred to nitrocellulose or polyvinylidene difluoride membranes and detected with specific antibodies and HRP-conjugated secondary antibodies in combination with enhanced chemiluminescence or SuperSignal Femto western blotting substrate (Thermo Scientific). Signal was acquired with Image Quant LAS 4000 V 1.2 and densitometric quantification was carried out with ImageJ. For MLC and pMLC immunoblotting, each sample was loaded on two separate gels. One gel was used to detect MLC and the second was used to detect pMLC. Both gels had their own loading control, namely α-tubulin. pMLC/MLC was quantified as follows: (pMLC/α-tubulin)/(MLC/α-tubulin), abbreviated in the figure panel as (c)pMLC/(c)MLC with (c) meaning 'corrected for corresponding loading control' . Membrane versus cytosolic protein fractions were purified with the Plasma Membrane Protein Extraction Kit (101Bio) according to the manufacturer's guidelines and using proprietary buffers. For co-immunoprecipitation (co-IP) of endogenous or overexpressed proteins, ECs were lysed by rotating at 4 °C for at least 4 h in co-IP lysis buffer (20 mM Tris-HCl pH8, 137 mM NaCl, 10% glycerol, 1% nonidet NP-40 and 2 mM EDTA). Equal amounts of protein were incubated overnight with specific antibodies or matching isotype control IgGs at 4 °C. Subsequently, 20 µl of protein A/G-sepharose beads was added to the immune complexes for 4 h at 4 °C under gentle rotation. The beads were pelleted, washed three times with ice-cold co-IP lysis buffer and boiled for 5 min in reducing agent and loading buffer before SDS-PAGE. To determine the effect of deleting the first 20 N-terminal amino acids of RHOJ on its interaction with GS, co-IPs were carried out as above on ECs simultaneously overexpressing GS and RHOJ-eGFP or ΔN20-RHOJ-eGFP. In some of the experiments, the expression of the ΔN20-RHOJ-eGFP was lower than the expression of RHOJ-eGFP. To correct for this possible bias, densitometric quantification of all bands was performed in ImageJ and signals in the immunoprecipitation lanes were normalized to the input signals. The amount of GS immunoprecipitated was the same under the RHOJ-eGFP and ΔN20-RHOJ-eGFP conditions (data not shown). Biochemical and metabolic assays. Bicinchoninic acid assay. The BCA protein assay kit (Pierce) was used to determine protein content with Gen5 1.11.5 (BioTek Instruments). Lactate dehydrogenase release. This was determined as a measure of cell survival using the Cytotoxicity Detection Kit (Roche Applied Science) with Gen5 1.11.5 (BioTek Instruments). Intracellular reactive oxygen species. Levels were determined by CM-H 2 DCFDA dye (5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetyl ester; Invitrogen) labelling following the manufacturer's guidelines. Glutamine synthetase activity. The enzyme activity in living cells was determined by pulse-labelling the cells for 30 min with 2 mM 15 NH 4 Cl and subsequent determination of 15 N incorporation in intracellular glutamine by gas chromatography-mass spectrometry (GC-MS). Similarly, GS activity was measured by pulse-labelling for 30 min with 0.5 mM [U- 13 C]glutamic acid and subsequent tracing of 13 C into glutamine by GC-MS. The 0.025 mM glutamine condition was added to this assay for the sole purpose of having a positive control-lowering external glutamine levels should increase GS activity-and does not in any way reflect maximal GS activity. Background signals were determined by pre-incubating the cells with the GS inhibitor MSO. As an independent method (not relying on labelling one of the immediate substrates (NH 4 + or glutamate)) of determining GS activity, we performed steady-state labelling of ECs with [U- 13 C]glucose (5.5 mM) and determined the 13 C contribution to α-ketoglutarate, glutamate and glutamine (for labelling scheme, see Extended Data Fig. 5f ). Before derivatization for GC-MS analysis, cells were washed with ice-cold 0.9% NaCl and extracted in ice-cold 80/20 methanol/water. Glutamine uptake assay. Dynamic [U- 13 C]glutamine uptake assays were performed as follows: 2.5 × 10 5 cells per well were seeded in 6-well plates and pulse-labelled for 0, 0.5, 10, 20 and 30 min with the regular M199 culture medium containing 0.6 mM [U- 13 C]glutamine instead of the regular 0.6 mM unlabelled glutamine. The 0-min time point represents an absolute negative control for which extracts were made from ECs that had never been treated with tracer-containing medium. For the 0.5-min time point, the labelled medium was put on the cells and immediately aspirated (altogether taking 0.5 min). At all time points, cells were thoroughly washed twice with ice-cold 0.9% NaCl to ensure complete removal of tracer-containing medium. Cellular extracts were then made in ice-cold 80/20 methanol/water, before derivatization for GC-MS measurements. Alternatively, cells were incubated with 0.5 µCi ml −1 [U-
14
C]-l-glutamine for 10 min, after which they were washed at least three times with ice-cold PBS. The last PBS wash was collected and checked for residual radioactivity. Cells were then lysed with 200 µl 0.2 M NaOH and lysates were neutralized with 20 µl 1 M HCl and used for scintillation counting. . A linear gradient using solvent A (50 mM NaH 2 PO 4 , 4 mM tetrabutylammonium, adjusted to 
Protein (auto)palmitoylation detection. In vitro palmitoylation (click-reactionbased).
Purified bacterial GS protein was incubated with the indicated concentration of palmitoyl alkyne-CoA (Cayman Chemical) for 6 h at room temperature. The GS protein was then denatured by the addition of SDS. A click reaction with biotin azide was performed to label the palmitoylated proteins 25 . Palmitoylated proteins were detected by SDS-PAGE followed by blotting with streptavidinhorseradish peroxidase. Fluorescence-based CoA release detection. During autopalmitoylation of proteins, palmitate is transferred from palmitoyl-CoA to the protein, thereby releasing reduced CoA. α-Ketoglutarate dehydrogenase can use CoA to convert α-ketoglutarate to succinyl-CoA, a reaction that features the reduction of NAD + to fluorescent NADH 31 . In brief, recombinant human GS was incubated with palmitoyl-CoA in MES buffer at physiological pH for at least 1 h at 30 °C. The volume was then adjusted to 200 µl in 50 mM sodium phosphate buffer (pH 6.8) containing 2 mM α-ketoglutaric acid, 0.25 mM NAD + , 0.2 mM thiamine pyrophosphate, 1 mM EDTA, 1 mM dithiothreitol and 32 mU α-ketoglutarate dehydrogenase. NADH levels were measured at 20 min after initiation of the reaction on a VICTOR plate reader (340 nm excitation, 465 nm emission). The experiment was performed in two directions: either with varying doses of palmitoyl-CoA for a fixed amount of recombinant GS (2 µg) or with varying amounts of recombinant GS for a fixed concentration of palmitoyl-CoA (40 µM). Affinity chromatography. A previously published protocol was used to determine cell-free binding of recombinant human GS to palmitoyl-CoA agarose 32 . A total of 50 µl of immobilized palmitoyl-CoA-agarose was equilibrated with 20 mM Tris-HCl (pH 8.4)/120 mM NaCl buffer. The beads were incubated with 40 µg of recombinant human GS in a final volume of 200 µl for 2 h at room temperature on a rotatory system. Beads were pelleted and 20 µl of the supernatant was collected as the flow-through fraction. Beads were then washed eight times with 500 µl of 20 mM Tris-HCl (pH 8.4)/120 mM NaCl buffer. Twenty microlitres of the last wash fraction was collected as fraction wash-8. Beads were then eluted with SDS loading buffer and heated for 15 min at 60 °C. Two micrograms of recombinant protein was used as input fraction. Input fraction, flow-through, wash-8 and SDS-eluate were analysed by immunoblotting for the presence of GS. In-cell labelling. In-cell labelling experiments were performed essentially as previously described 25 . HEK-293T cells were transfected with the indicated expression plasmids. Twenty-four hours after transfection, the medium was replaced with DMEM + 10% dialysed FBS containing the indicated probes (50 µM 16C-YA or 50 µM 16C-BYA). After 18 h, cell lysates were collected by incubation of the cells on ice for 15 min in lysis buffer (50 mM TEA-HCl (pH = 7.4), 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS and 5 mM phenylmethanesulfonyl fluoride) followed by centrifugation for 10 min at 15,000g. Equal amounts of protein were then used for a click reaction with biotin azide. For labelling with 17-ODYA, Flag-RHOJ overexpressing ECs were incubated overnight with 17-ODYA (50 µM) in M199 supplemented with 3.6% fatty-acid-free BSA, 10% dialysed FBS and 5 mM sodium pyruvate. Cells were washed with ice-cold PBS and lysed in NaP lysis buffer (0.2 M Na 2 HPO 4 ·2H 2 O, 0.2 M NaH 2 PO 4 ·2H 2 0, 1 M NaCl, 10% NP40). Two micrograms of anti-Flag antibody was conjugated to 20 µl of Dynabeads protein G (Thermo Fisher) for 1 h at room temperature. After washing the beads twice with NaP lysis buffer, at least 500 µg of protein was added to the beads for 3 h at 4 °C. Then beads were washed three times with NaP lysis buffer and resuspended in 20 µl of resuspension buffer (4% SDS, 50 mM TEA, 150 mM NaCl). The click reaction was initiated by adding 0.5 µl of 5 mM TAMRA-azide (Lumiprobe), 0.5 µl 50 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEPHCl), 0.5 µl 10 mM tris[ (1-benzyl-1H-1,2,3 -triazol-4-yl)methyl]amine (TBTA) and 2.4 µl of 5 mM freshly prepared ascorbic acid. Samples were then incubated for 1 h at 37 °C in the dark. Sample buffer (9.4 µl) and reducing agent (3.7 µl) were added to stop the reaction. After 10 min at room temperature in the dark, samples were frozen at −80 °C or run on a 10% Bis-Tris gel in MES buffer. In-gel fluorescence was imaged with Typhoon FLA 9500 V1.0. Streptavidin pull-down. After click reaction with biotin azide, free biotin azide was removed from the samples by centrifugal filtration column (Millipore). The samples were then incubated with streptavidin-conjugated beads for 1 h at room temperature. After washing with PBS-T, proteins were eluted from the beads by incubation in elution buffer (95% formamide, 10 mM EDTA (pH = 8.0)) at 95 °C for 5 min. Acyl-resin-assisted capture. This method, in which free cysteine thiols are chemically blocked and palmitoylated cysteines are exposed and captured by a resin, was performed with the CAPTUREome S-Palmitoylated Protein Kit (Badrilla) with minor adaptations to the manufacturer's guidelines. Five hundred micrograms of protein were incubated for 4 h in 500 µl of thiol blocking reagent (to block free thiols). Proteins were precipitated with ice-cold acetone and afterwards solubilized with 300 µl of binding buffer and spun down. After protein quantification, 30 µg was kept as total input fraction (IF), and equal amounts of protein were incubated for 2.5 h with or without (to obtain the negative control preserved bound fraction pBF) a thioester linkage specific cleavage reagent to cleave the thioester bond. Newly liberated thiols were captured with CAPTUREome resin. The resin was spun down and the supernatant was collected as the cleaved unbound fraction (cUF) to check whether the proteins of interest were indeed completely depleted from the thioester cleavage reagent (meaning efficient capture of the free thiols by the resin). After thorough washing of the resin, captured proteins (cleaved bound fraction, cBF), were eluted with reductant and analysed together with the input fraction, cleaved unbound fraction and preserved bound fraction by SDS-PAGE followed by immunoblotting. GC-MS analysis. Metabolites from cells were extracted in 800 µl 80% methanol (at −80 °C). Next the extracts were centrifuged at 4 °C for 15 min at 20,000g and the supernatants were dried in a vacuum centrifuge. Twenty-five microlitres of a 2% methoxyamine hydrochloride solution (20 mg dissolved in 1 ml pyridine) was added to the dried fractions, which were then incubated at 37 °C for 90 min. Then 75 µl of N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide with 1% N-tertbutyldimethylchlorosilane (Sigma-Aldrich) was added and the reaction was carried out for 30 min at 60 °C. Reaction mixtures were centrifuged for 15 min at 20,000g at 4 °C to remove insolubilities and the supernatant was transferred to a glass vial with conical insert (Agilent). GC-MS analyses were performed on an Agilent 7890A GC equipped with a HP-5 ms 5% Phenyl Methyl Silox (30 m, 0.25 mm internal diameter, 0.25 µm; Agilent Technologies) capillary column, interfaced with a triple quadrupole tandem mass spectrometer (Agilent 7000B, Agilent Technologies) operating under ionization by electron impact at 70 eV. The injection port, interface and ion source temperatures were kept at 230 °C. The temperature of the quadrupoles was kept at 150 °C. The injection volume was 1 µl, and samples were injected at a 1:10 split ratio. The helium flow was kept constant at 1 ml min
. The temperature of the column started at 100 °C for 5 min and increased to 260 °C at 2 °C min −1
. Next, a 40 °C min −1 gradient was applied until the temperature reached 300 °C. After the gradient, the column was heated for another 3 min at 325 °C. The GC-MS analyses were performed in single-ion-monitoring scanning mode for the isotopic pattern of metabolites. LC-MS analysis. Polar metabolites were extracted using 250 µl of a 50/30/20 methanol/acetonitrile/10 mM ammonium acetate pH 9.3 (containing 2 µM of deuterated (d27) myristic acid as internal standard) extraction buffer. Following extraction, precipitated proteins and insoluble matter were removed by centrifugation at 20,000g for 20 min at 4 °C. The supernatant was transferred to the appropriate mass spectrometry vials. Measurements were performed using a Dionex UltiMate 3000 LC System (Thermo Scientific) in-line connected to a Q-Exactive Orbitrap mass spectrometer (Thermo Scientific). Fifteen microlitres of sample was injected and loaded onto a Hilicon iHILIC-Fusion(P) column (Achrom). A linear gradient was applied starting with 90% solvent A (LC-MS grade acetonitrile) and 10% solvent B (10 mM ammonium acetate pH 9.3). From 2 to 20 min the gradient changed to 80% B and was kept at 80% until 23 min. Next a decrease to 40% B was applied to 25 min, further decreasing to 10% B at 27 min. Finally, 10% B was maintained until 35 min. The solvent was used at a flow rate of 200 µl min −1 , the column temperature was kept constant at 25 °C. The mass spectrometer operated in negative-ion mode, and the settings of the HESI probe were as follows: sheath gas flow rate at 35, auxiliary gas flow rate at 10 (at a temperature of 260 °C). Spray voltage was set at 4.8 kV, temperature of the capillary at 300 °C and S-lens RF level at 50. A full scan (resolution of 140,000 and scan range of m/z 70-1,050) was applied. For the data analysis, we used an in-house library and metabolites of interest were quantified (area under the curve) using the XCalibur 4.0 (Thermo Scientific) software platform. In vitro assays. Endothelial spheroid capillary sprouting. The assay was performed following established protocols 1, 2 . To form the spheroids, ECs were cultured overnight in hanging drops in EGM2 medium with methylcellulose (Sigma-Aldrich; 20% volume of a 1.2% solution of methylcellulose viscosity 4,000 cP). Spheroid sprouting involves both EC proliferation and migration. To have a 'clean' view on the migration aspect in sprouting, we also included conditions in which we blocked EC proliferation before sprout formation. More precisely, mitotic inactivation was achieved by adding mitomycin C (1 µg ml
) to the medium. To induce sprouting, spheroids were embedded in a collagen gel and incubated for 20 h. If required, chemical compounds (Fasudil at 10 µM, H1152 at 1 µM and Y26732 at 10 µM) were added during the collagen-gel-incubation step. Spheroids were then fixed with 4% paraformaldehyde and imaged under phase-contrast illumination with a Motic AE 31 microscope (Motic Electric Group) or a Leica DMI6000B microscope (Leica Microsystems). Phase-contrast images were used to quantify the number of sprouts per spheroid and the total sprout length (cumulative length of all sprouts on a spheroid). Spheroid body circumference was measured to correct for differences in sizes of the spheroid. Per experiment (that is, per individual HUVEC isolation) at least 10 spheroids per condition were analysed. Scratch wound assays. Seventy-five thousand HUVECs were seeded in a 24-well format and were allowed to reach confluency over the next 24 h. At time T 0 the confluent monolayer was scratched with a 200-µl pipette tip and photographed. The cells were further incubated for the indicated times and photographed again at time point T x . The gap area at T 0 minus the gap area at T x was measured with ImageJ and expressed as % migration distance. Per well, three non-overlapping regions along the scratch were analysed. Much like the spheroid sprouting, scratch wound healing is a combined readout for EC migration and proliferation. Therefore, we also included conditions in which the ECs were pre-treated with mitomycin C (1 µg ml −1 ) to rule out the effect of proliferation. Boyden chamber assays. Fifty thousand HUVECs were seeded on 0.1% gelatincoated transwells and allowed to adhere. Then, the transwells were washed and refed with medium containing only 0.1% FBS and placed in bottom wells containing medium with 5% FBS as a pro-migratory stimulus. Sixteen hours later, transwells were processed and analysed for numbers of migrated cells. Pre-treatment with mitomycin C (see above) was applied. Velocity of random movement. This was assessed on HUVECs that were sparsely seeded on glass-bottom 24-well plates. Time-lapse videos were generated by confocal image acquisition at 4-min intervals. Velocity of movement was determined by tracking the nucleus position as a function of time (µm h −1 ) (Tracking Tool, Gradientech AB). Per condition, on average 2 or 3 individual cells were traced in each biological repeat. Lamellipodial area. This was measured on sparsely seeded phalloidin-stained ECs with Leica MM AF morphometric analysis software (Leica Microsystems) with in-house-developed macros and is expressed in percentage of total cell area. Treatment with MSO (1 mM), Y27632 (10 µM), fasudil (10 µM), H1152 (1 µM), ML7 (15 µM) and peptide 18 (15 µM) was carried out 24 h before analysis of the cells. Per experimental condition, a minimum of ten individual cells was analysed.
Staining and quantification of VE-cadherin junctions. VE-cadherin staining and quantification of junctional length and gap index was performed as previously described 33 . First, the total junctional length (100%) was determined by summing up all segments, then the sum of all continuous segments was calculated as the percentage of total junctional length. The percentage difference between total and continuous represents the discontinuous length. Gap size index (intercellular gap area/cell number) was determined with the formula ([intercellular gap area/total cell area] × 1,000)/cell number. Junctional lengths, intercellular gap area and total cell area were defined manually with ImageJ. For each condition, a minimum of 10 fields was quantified (10-15 cells per field on average) per experiment, and data shown represent the mean of at least three independent experiments. Transendothelial electrical resistance. Fifty thousand ECs were seeded on 6.5-mm 0.1% gelatin-coated polyester transwells, 0.4-µm pore size (Costar ref. 3470, SigmaAldrich). The electrical resistance was measured with an Endhome-6 electrode (World Precision Instruments) connected to an EVOM2 voltohmmeter (World Precision Instruments). Gelatin-coated wells without cells were used to measure the intrinsic electrical resistance of the inserts for background subtraction. Measurements were performed every day for four consecutive days, with at least two measurements per c on di ti on.
Actin dynamics and Rho (kinase) activity assays. Latrunculin wash-out. ECs were treated with latrunculin B (100 ng ml −1 ) for 30 min and were then washed three times with culture medium. The cells were fixed at the indicated time points and stained with phalloidin to visualize actin stress fibres. The F-actin/G-actin ratio. The ratio was determined for GLUL KD versus control ECs, in 4% paraformaldehyde-fixed cells that were permeabilized for 10 min in PBS with 0.2% Triton X-100 and stained with phalloidin-Alexa 488 and DNase I-Alexa 594 (1:200) 34 . Fluorescence intensities were quantified with ImageJ and were based on grey values. On average, ten individual cells were analysed per experimental condition. RHOJ activity measurements. Cells were lysed in buffer containing 50 mM Tris, pH 7.6, 150 mM NaCl, 1% Triton X-100, 0.5 mM MgCl 2 , protease inhibitors and 0.1 µg µl −1 biotinylated CRIB-peptide. After spinning down for 4 min at 18,000g at 4 °C, 50 µl streptavidin-coated beads was added to the lysates. Subsequently, samples were rotated for 30 min at 4 °C, beads were washed 4 times in the above buffer after which they were boiled for 5 min in reducing agent and loading buffer 35 . As negative controls in this assay, we used lysates from RHOJ KD ECs, a streptavidin-beads only-condition and lysates in which the biotinylated CRIB-peptide was replaced by an irrelevant biotinylated protein (Fig. 4c) . RHOA/B/C activity. This was determined with glutathione S-transferase-Rhotekin pull down assays following previously established protocols . In brief, a Zeiss Observer Z1 microscope, with a Chroma 510 DCSP dichroic splitter, two Hamamatsu ORCA-R2 digital CCD cameras and an attached dual camera adaptor (Zeiss) controlling a 510 DCSP dichroic mirror, was used for simultaneous monitoring of CFP and YFP emissions using filter sets ET 480/40 and ET 540/40m (Chroma Technology), respectively. To excite the CFP donor, ET 436/20x and 455 DCLP dichroic mirror was used (Chroma). For FRET/CFP ratiometric processing, CFP and YFP images were processed using the MBF ImageJ collection. The images were background-subtracted, aligned and a threshold was applied. Finally, the FRET/CFP ratio was calculated and a custom lookup table was applied to generate a colour-coded image, in which white and red colours illustrate high and blue colours illustrate low RHOA activities. BiFC imaging and quantification. BiFC was evaluated using a laser scanning microscope (Fluoview FV1000, Olympus) equipped with a UPLSAPO 60× oil objective (NA 1.35). Before imaging, cells were fixed with 4% (v/v) paraformaldehyde and stained with 4ʹ,6-diamidino-2-phenylindole (DAPI; 1:1,000 dilution, Invitrogen). A 488-nm laser was used for exciting eGFP, whereas DAPI was excited using a 405-nm laser. A DM405/488/559/635 polychroic mirror was used to guide the excitation lasers to the sample. Fluorescence images of fixed cells were acquired using a sampling speed of 4 µs per pixel. Emission light was collected at 430-470 nm and 500-550 nm, for DAPI and eGFP, respectively. The images were acquired with a pixel size of 207 nm (1,024 × 1,024 pixels). BiFC was first established in HEK cells expressing GS-eGFP 1/2 and RHOJ-eGFP 2/2 from one expression vector, with a construct overexpressing an unfused N-terminal eGFP half-site together with RHOJ coupled to the C-terminal eGFP half-site as a negative control (data not shown). To determine the effect of deleting the first 20 amino acids in RHOJ on BiFC in ECs, separate expression constructs for GS-eGFP 1/2 , RHOJ-eGFP 2/2 and ΔN-RHOJ-eGFP 2/2 were used (Extended Data Fig. 7e ). Quantification of expression efficiency was carried out using an in-house-generated routine in MATLAB. TIRF microscopy. An in-house-generated setup based on an inverted microscope (IX83, Olympus) was used to detect single molecules under total internal reflection (TIRF) mode. The setup was equipped with an Electron Multiplying-CCD cameras (ImagEM C9100-13; Hamamatsu Photonics) and an APON 60XOTIRF objective lens (NA 1.49, Olympus). The GS-mEos3.2 molecules were excited with a 561-nm line from a DPSS laser (200 mW; Coherent) and converted with a 405-nm line from a diode laser (Cube, 100 mW; Coherent). Before expansion, the laser lines were combined using a 405bcm dichroic mirror. The laser lines were guided onto the sample by a dichroic mirror, z488/561/633rpc. The red fluorescence of the mEos3.2 was detected through a long-pass filter 572 (HQ572LP), in combination with a band-pass filter HQ590M40-2P. All the filters were purchased from Chroma. Time-lapse fluorescence images were recorded with continuous illumination at a 62.5-Hz acquisition rate (16 ms per frame).
Article reSeArcH
Single-particle tracking. For calculation of single-molecule coordinates, the program 'Localizer' running from MATLAB was used 38 . After localization, the positions of a molecule detected in consecutive frames are connected to reconstruct a trajectory using in-house-developed software in MATLAB. Coordinates presented in consecutive frames are linked to form a single trajectory when they uniquely appear at a distance smaller than 856 nm (corresponding to 8 pixels). Trajectories with at least three steps were analysed using variational Bayes single-particle tracking analysis (vbSPT), a software package for analysis of single-particle diffusion trajectories, in which the diffusion constants switch randomly according to a Markov process 39 .
For experiments involving microscopic analysis of individual (immuno-)stained cells, initial confocal image acquisition was done by researchers blinded to the experimental condition to avoid biased imaging of cells presenting a certain phenotype. Data Fig. 1d, e) .
Mice
Generation of Glul
+/GFP chimaeras. Blastocysts were collected from superovulated C57BL/6 females at post-coital day 3.5 and were cultured for 5-8 days in ES cell culture medium consisting of Knockout DMEM medium (Invitrogen), with 2 mM l-glutamine, FBS (Hyclone, Thermo Scientific), MEM non-essential amino acids 100X (Invitrogen), 0.01 mM β-mercaptoethanol (Sigma-Aldrich), 1 mM sodium pyruvate (Invitrogen), 100 U ml −1 penicillin, 100 µg ml −1 streptomycin and 2,000 U ml −1 leukaemia inhibitory factor (Merck, Millipore). Afterwards, the inner cell mass was selectively removed from the trophectoderm, trypsinized and replated on a mitomycin C-arrested MEF feeder monolayer. ES cells were fed every day and passaged every 2-4 days onto new feeder cells. Glul +/GFP ES cells (E14IB10 ES cell line) 6 were injected into C57BL/6 blastocysts and high chimaeric pups were killed at P5 for detection of GFP in the retinal microvasculature. In vivo models. Analysis of dorsal dermal blood vessel network. From E11.5 to E13.5 (where detection of the vaginal plug was designated E0.5), Glul vECKO pregnant dams were treated with tamoxifen (50 mg kg ) by oral gavage. At E16.5 they were euthanized by cervical dislocation after which embryos were dissected from the uterus. Yolk sacs were collected, washed with PBS and used for genotyping of the embryos. The embryos were fixed for 10 min in 1% paraformaldehyde before dissection of the dorsal skin. The epidermal and dermal layers were separated under a dissection microscope. Dissected back skins were permeabilized overnight (0.5% Triton X-100, 0.01% sodium deoxycholate, 1% bovine serum albumin, 0.02% sodium azide) before whole-mount immunostaining with CD31. To systematically analyse the same region for each embryo, 1 rectangular confocal image (1,700 × 1,100 µm) was taken at the anterior side of the skin specimen with the upper longer side of the rectangle placed on the midline. Within each rectangular picture the number of branch points was determined with the cell counter tool in ImageJ in 6 regions of interest (ROIs) (250 × 250 µm), three in the top half and three in the bottom half of the rectangle, not overlapping with the larger arteries and veins. Neonatal retinal angiogenesis. EC-specific Glul deletion was obtained by intraperitoneal administration of tamoxifen (Sigma; 10 mg kg
; dissolved in 1:10 ethanol: oil solution) once daily from P1 to P3 in Glul vECKO or once at P2 for Glul pECKO . For in vivo proliferation quantification, EdU (Invitrogen) was injected intraperitoneally 2 h before euthanasia. Unless stated otherwise, retinas were isolated at P5 as previously described 43 and fixed in 2% paraformaldehyde for 2 h. Isolectin B4 (IB4), EdU, NG2 and ColIV stainings were performed as previously described 1, 2 . Radial outgrowth of the vascular plexus, vascular area, branch points, number of filopodia and number of distal sprouts were analysed on IB4-stained retinas (see below) with ImageJ. Numbers of branch points and EdU + ECs were quantified in 200 × 200-µm ROIs; per retina 12 ROIs were placed at the front of the vascular plexus and 8 ROIs were placed more towards the centre of the plexus. Filopodia and distal sprouts were quantified on ten high-magnification (63×) images per retina, each representing approximately 200 µm of utmost vascular front. For analysis of the retinal vasculature at P21 (3 weeks old) and P42 (6 weeks old), mice underwent the same tamoxifen treatment regimen as for analyses at P5. In addition, different tissues were collected from P42 mice for endoglin and CD34 staining to study blood vessels in different vascular beds. Oxygen-induced retinopathy. Oxygen-induced ROP was induced by exposing C57BL/6 pups to 70% oxygen from P7-P12. Pups were then returned to normoxia and injected daily with 20 mg kg −1 MSO. At P17, pups were euthanized and eyes were enucleated, fixed in 4% paraformaldehyde and retinal flatmounts were stained for isolectin B4 2, 3 . MSO-treated mice retained normal behaviour notwithstanding observable weight loss. Mosaic tile images were captured using the inverted Leica DMI6000B epifluorescence microscope (Leica) and analysis of the vascular tuft area (the complete retina was analysed, no ROIs were used) and the vaso-obliterated area was performed with ImageJ software and are expressed as percentage of the total retinal area.
Corneal (micro-)pocket assay. This assay, to induce neovascularization of the avascular cornea, was performed as previously described 44 . In brief, in the eyes of eight-week-old C57BL/6 mice, a lamellar micropocket was dissected towards the temporal limbus to enable the placement of a basic fibroblast growth factor (bFGF)-containing pellet on the corneal surface. Five days after implanting the pellets, the mice were euthanized, the eyes were enucleated and the corneas were excised and fixed in 70% ethanol before CD31 antibody staining. After staining, the corneas were flat-mounted and imaged on a Zeiss LSM 780 confocal microscope. CD31
+ area was measured in ImageJ after thresholding the signal and is expressed as percentage of total cornea area. Production of the pellets was carried out as previously described 44 . The pellets contained 20 ng bFGF and the concentration of MSO in the initial solution from which the pellets were made was 10 mM. Imiquimod-induced skin inflammation. Ten-week-old female BALB/C mice received a daily topical dose of 5% imiquimod cream (62.5 mg) on their shaved backs for four days to induce skin inflammation ). The MSO treatment did not affect the body weight of the mice. Skins were collected and fixed in 4% paraformaldehyde. Paraffin sections of skins were stained for CD105 (R&D Systems) and haematoxylin and eosin. Images were captured with a Leica DMI6000B microscope (Leica Microsystems). Per mouse, ten images representing different locations along the total length of the skin specimen were analysed for CD105 + area. Miles vascular permeability assay. Eight-week-old female BALB/C mice were treated for three consecutive days with 20 mg kg −1 day −1 MSO or with vehicle before injection with 300 µl 0.5% Evans blue dye. The inflammatory irritant mustard oil (0.25 ml allyl isothiocyanate in 4.75 ml mineral oil) was applied on one of the ears with a cotton swab to induce vascular permeability. Mineral oil as a control was applied on the other ear. After 15 min, mustard oil or mineral oil was again applied on the ear for 30 min, after which the circulation was flushed with saline for 3 min under complete anaesthesia and mice were perfused with 1% paraformaldehyde in 50 mM citrate buffer (pH 3.5) for 2 min. Ears were cut and minced in formamide and incubated at 55 °C overnight to extract the Evans blue from the tissue. Quantification of the dye was performed by a spectrophotometrical optical density measurement at 620 nm. Haematological profiling in six-week-old mice. Profiling was performed with a Cell Dyn 3700 device (Abbott Diagnostics) according to the manufacturer's guidelines. Plasma measurements for different liver and inflammation parameters were performed in the clinical laboratory of UZ Leuven. Prior randomization was not applicable for any of the above mouse models given that all animal treatments were performed in baseline conditions. No statistical methods were used to predetermine the sample size. For all mouse experiments, data analysis was carried out by researchers blinded to the group allocation. All animal procedures were approved by the Institutional Animal Care and Research Advisory Committee of the University of Leuven. In silico screening for palmitoylation sites. The human RHOJ protein sequence was screened for putative palmitoylation sites on the SwissPalm website 22 entering 'RHOJ' as the protein name. Modelling and simulations. The GS models were built starting from X-ray crystallographic structures retrieved from the Protein Data Bank (entry 2OJW for human GS and 1FPY for bacterial GS). All simulations were run with Gromacs 5.1.4 45 and the Amber FF14SB 46 force field, while palmitoyl-CoA was parametrized with GAFF and the point charges were calculated with Gaussian 09 47 at the HartreeFock level with a 6-31G* basis set. The different models were then embedded in a TIP3P water box, and counter ions were added to ensure overall charge neutrality. An initial 2,000 steps of steepest descent and 500 steps of conjugated gradient were applied to minimize the geometry and remove steric clashes, followed by 10 ns of isothermal-isobaric (NPT) equilibration. The Berendsen barostat was applied to keep the pressure around 1 atm, while the temperature of 300 K was maintained throughout all the simulations with the V-rescale algorithm 48 . Molecular dynamics production runs (500-ns long) were carried out for all the systems in the canonical (NVT) ensemble, for a cumulative total of 2.5 µs. The particle mesh Ewald (PME)-Switch algorithm was used for electrostatic interactions with a cut-off of 1 nm, and a single cut-off of 1.2 nm was used for Van der Waals interactions. Four simulations for human GS and two for the GS of Salmonella typhimurium were run by placing the CoA moiety close to the adenosine binding site and allowing different initial positions for the palmitoyl tail. The CoA head invariably docked and remained tightly bound to the adenine binding site in all simulations. Among these, two favourable alternative arrangements (Extended Data Fig. 8b ) for the tail were identified in both systems. In one of these conformations, the beginning of the palmitate tail (from the point of view of the CoA moiety) approaches very close to the conserved CYS209 (human residue numbering, conformation A in Extended Data Fig. 8b , details in Extended Data Fig. 8c) , and in the other conformation (conformation B in Extended Data Fig. 8b, details in Extended Data Fig. 8d ) it approaches the conserved Ser65 and 75. Multiple sequence alignments. A multiple sequence alignment of the GS protein across different species was performed with the Basic Local Alignment Search Tool (BLAST). The algorithm matches sequences according to local similarity, by optimizing their maximal segment pair score (MSP). The 100 matches with the highest identity to the Homo sapiens sequence surrounding amino acid C209 were taken from the UniProtKB/Swiss-Prot refined database. Statistical analysis. Data represent mean ± s.e.m. of pooled experiments unless otherwise stated. Scatters in bar graphs represent the values of independent experiments or individual mice. In cases for which individual values are very similar, scatter points overlap and may no longer be visible as individual points. n values represent the number of independent experiments performed or the number of individual mice phenotyped. Statistical significance between groups was calculated with one of the following methods: for comparisons to point-normalized data, a two-tailed one-sample t-test was used in GraphPad Prism7. For pairwise comparisons, two-tailed unpaired t-tests were used in GraphPad Prism7. For multiple comparisons within one dataset, one-way ANOVA with Dunnett's multiple comparison (comparing every mean with the control mean rather than comparing every mean with every other mean) was used in GraphPad Prism7. Mixed-model statistics (this test does not assume normality or equal variance) was used with the experiment as a random factor only in cases for which confounding variation in baseline measurements between individual EC isolations (for each experiment, ECs were freshly isolated from individual human umbilical cords) or mouse litters precluded the use of the above statistical tests. For this, R and the lme4 package were used; P values were obtained with the Kenward-Roger F-test for small mixed-effect model datasets. In the most severe cases, the individual data points (each data point being the mean of the technical replicates within an experiment or an individual mouse) in the bar graphs have been colour-coded per experiment or per litter to show the baseline variation. The sample size for each experiment was not predetermined. A P value <0.05 was considered significant. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Data availability. Figures 1, 4, 5 and Extended Data Figs. 1, 7, and 8 have associated raw data (uncropped blots and/or gel pictures) in Supplementary Fig. 1 . ; GLUL KD1 is used in the experiments in the text and is denoted GLUL KD ) or transfected with scrambled siRNA (SCR) or siRNA targeting GLUL (siGLUL). Data are expressed as a percentage of the respective control, denoted by the horizontal dotted line (mean ± s.e.m.; n = 28 independent experiments for GLUL KD1 , n = 3 independent experiments for GLUL KD2 and n = 9 independent experiments for siGLUL; *P < 0.05 versus the respective control; one-sample t-test). b, c, Quantification of number of sprouts (b) and total sprout length (c) for spheroid-sprouting assays with GLUL KD ECs and GLUL KD ECs expressing a shRNA-resistant GLUL mutant (rGLUL OE ) (mean ± s.e.m.; n = 3 independent experiments; *P < 0.05 and NS, P > 0.05 versus control; one-way ANOVA with Dunnett's multiple comparison versus control). d, Viability of control (Ctrl) and GLUL KD ECs as measured by lactate dehydrogenase (LDH) release assay (mean ± s.e.m.; n = 3 independent experiments; NS, P > 0.05 versus control, one-sample t-test). e, Intracellular levels of reactive oxygen species measured by CM- control ECs (mean ± s.e.m.; n = 3 independent experiments; NS, P > 0.05 versus control, Student's t-test). g, Ratio of oxidized glutathione (GSSG) over total glutathione levels (GSSG/(GSH + GSSG)) in GLUL KD and control ECs (mean ± s.e.m.; n = 4 independent experiments; NS, P > 0.05 versus control, Student's t-test). h, NADP/NADPH ratio in GLUL KD and control ECs (mean ± s.e.m.; n = 5 independent experiments; NS, P > 0.05 versus control, one-sample t-test). i-k, Effect of GLUL knockdown on major metabolic fluxes including glycolysis (i), glucose oxidation (j) and glutamine oxidation (k) (mean ± s.e.m.; n = 3 independent experiments for i, n = 5 for j and n = 4 for k; NS, P > 0.05 versus control, one-sample t-test). l, m, Oxygen consumption rate (OCR) in control, MSO-treated and GLUL KD ECs in basal state and after injection of oligomycin, FCCP and antimycin A (l) (mean ± s.e.m.; n = 3 independent experiments), and calculation of OCR BAS , OCR ATP and maximal respiration (m) (mean ± s.e.m.; n = 3 independent experiments). 
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Sample size
Samples size for each experiment is indicated in the legends. The sample size was chosen based on previous experience in the lab, for each experiment to yield high power to detect specific effects. No statistical methods were used to predetermine sample size.
Data exclusions No data were excluded.
Replication
All experimental findings were reproduced in multiple independent experiments. For experiments in HUVECs, each independent experiment uses HUVECs isolated from an individual HUVEC donor. For each figure panel, the number of independent experiments or biological replicates is indicated in the figure legends. Data shown in figure panels are the mean of all independent biological repeats. Western blot pictures typically are from a representative experiment; however, the number of independent repeats is clearly indicated in the figure legends. Where applicable, the densitometric quantifications are the mean of the different independent experiments.
Randomization No formal randomization techniques were used.
Blinding
For experiments involving mice, initial data analysis was performed by researchers blinded to the group allocation. For experiments involving microscopic analysis of individual (immuno-)stained cells, initial confocal image acquisition was done by researchers blinded to the experimental condition to avoid biased imaging of cells presenting a certain phenotype.
Reporting for specific materials, systems and methods As detailed in the Methods section, these are the primary antibodies that were used in this study, with clone/catalog number
